Late-onset depression: Genetic, vascular and clinical contributions

Psychological Medicine

Volumn 31, Issue 8, 2001, Pages 1403-1412

  Hickie, I ^a,b   Scott, E ^a   Naismith, S ^a   Ward, P B ^a   Turner, K ^a   Parker, G ^a   Mitchell, P ^a   Wilhelm, K ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b St George Hospital and Community Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E2; APOLIPOPROTEIN E4;

ADULT; AGED; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEPRESSION; GENE MUTATION; GENETICS; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MULTIVARIATE ANALYSIS; ONSET AGE; PHENOTYPE; PREDICTION; PREVALENCE; PSYCHOMOTOR RETARDATION; RISK FACTOR;

EID: 0034760643     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0033291701004731     Document Type: Article

References (58)

1. 'Vascular depression' hypothesis
2. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions
3. ApoE allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia
4. Homocysteine, folate, methylation, and monoamine metabolism in depression
5. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
6. A brave new world in managing depression - Or is it?
7. Lessons from a mood disorders unit
8. Diagnostic validity and laboratory studies: Rules of the game
9. Cerebral white matter lesions and depressive symptoms in elderly adults
10. 12, and homocysteine in major depressive disorder
11. Predictors of an acute antidepressant response to fluoxetine and sertraline
12. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician
13. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation
14. A rating scale for depression
15. Homocysteine and vascular disease
16. Apolipoprotein E-ε4 allele frequency in late-onset depression
17. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample
18. Issues in classification: III. Utilising behavioural constructs in melancholia research
19. Late-onset depressive disorders: A preventable variant of cerebrovascular disease?
20. Prediction of response to electroconvulsive therapy: Preliminary validation of a sign-based typology of depression
21. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression
22. Magnetic resonance imaging in primary and secondary depression
23. Prediction of ECT response: Validation of a refined sign-based (CORE) system for defining melancholia
24. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression - A longitudinal evaluation
25. Cognitive function
26. Relation between folate status, a common mutation in methylene-tetrahydrofolate reductase, and plasma homocysteine concentrations
27. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study
28. Arteriosclerotic depression
29. Clinical and phenomenological comparisons of late-onset and early-onset depression
30. Apolipoprotein E-ε4 frequency in geriatric depression
31. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects
32. Psychiatric genetics: Search for phenotypes
33. Cognition and white matter hyperintensities in older depressed patients
34. Cerebrovascular risk factors and later-life major depression. Testing a small-vessel brain disease model
35. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease
36. Validity of the CORE: I. A neuroendocrinological strategy
37. High plasma homocysteine: A risk factor for vascular disease in the elderly
38. Apolipoprotein E ε4 allele and Japanese late-onset depressive disorders
39. Psychomotor change as a feature of depressive disorders: An historical overview
40. Endogenous depression as a construct: A quantitative analysis of the literature and a study of clinical judgements
41. Classifying depression by mental state signs
42. Psychosocial risk factors distinguishing melancholic and non-melancholic depression: A comparison of six systems
43. Defining melancholia: Properties of a refined sign-based measure
44. Subtyping depression, I. Is psychomotor disturbance necessary and sufficient to the definition of melancholia?
45. Issues in classification: II. Classifying melancholia
46. Validity of the CORE: III. Outcome and treatment prediction
47. Perspective: A mechanism underlying homocysteinemia and increased risk of coronary artery and cerebrovascular disease
48. Cerebrovascular disease and late life depression: An age old association revisited
49. MRI and neuropsychological differences in early- and late-life-onset geriatric depression
50. Apolipoprotein E phenotype is not related to late-life depression in a population-based sample
51. Subcortical hyperintensities in late-life depression: Acute response to treatment and neuropsychological impairment
52. A population study of apoE genotype at the age of 85: Relation to dementia, cerebrovascular disease, and mortality
53. Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions
54. Cerebrovascular disease and depression symptoms in the cardiovascular health study
55. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography
56. Psychomotor retardation: Clinical, theoretical, and psychometric aspects
57. Homocysteine and vascular disease
58. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C sub 677 T mutation